Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT02825498
Other study ID # C2016-012
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date May 18, 2016
Est. completion date December 2020

Study information

Verified date May 2020
Source Victoria Cardiac Arrhythmia Trials
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Radiofrequency ablation (RFA) is a standard treatment option for cavotricuspid isthmus (CTI) dependent atrial flutter. We plan to perform a randomized prospective trial comparing the efficacy of contact force (CF) guided CTI ablation against catheter ablation with the operator blinded to contact force parameters.


Description:

Subjects will be followed for one year post procedure in order to check for atrial flutter recurrences. This will involve an in-person visit at 3 months post procedure, and records checks at 12 months post procedure.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 100
Est. completion date December 2020
Est. primary completion date December 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult patients (over the age of 18) with 12 lead ECG documented paroxysmal or persistent CTI dependent atrial flutter planned to undergo CTI ablation.

- Able and willing to give informed consent.

Exclusion Criteria:

- Previous CTI ablation

- Previous non-CTI dependent atrial flutter (ie.patients with previous history of pulmonary vein isolation or left atrial ablation, congenital heart disease, surgical ablation)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Contact force guided RFA
Contact force guided RFA during Atrial Flutter ablation procedure.

Locations

Country Name City State
Canada Victoria Cardiac Arrhythmia Trials Victoria British Columbia

Sponsors (1)

Lead Sponsor Collaborator
Victoria Cardiac Arrhythmia Trials

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Efficacy of RFA Total RFA time required to achieve bidirectional block Determined during RFA procedure
Secondary Recurrence of atrial flutter Documented recurrence of atrial flutter Assessed at 12 weeks and 12 months post CTI RFA procedure
Secondary Average total CF achieved Average total CF per ablation per segment (third) of the CTI. Determined during RFA procedure
Secondary Average axial CF achieved Average axial CF per ablation per segment (third) of the CTI. Determined during RFA procedure
Secondary Average FTI achieved Average FTI per ablation per segment (third) of the CTI. Determined during RFA procedure
Secondary Average lateral CF achieved Average lateral CF per ablation per segment (third) of the CTI. Determined during RFA procedure
Secondary Average lesion size index (LSI) achieved Average lesion size index (LSI) per ablation per segment (third) of the CTI. Determined during RFA procedure
Secondary Procedural complication rate Incidence of procedural complications: stroke, cardiac perforation, steam pops, access site bleeding. Determined during RFA procedure and at 12 weeks post RFA procedure
Secondary Average total CF of segment of acute and delayed reconnection Average total CF per ablation in segment (third) of acute or delayed reconnection. Determined during index and repeat RFA procedure
Secondary Average lateral CF of segment of acute and delayed reconnection Average lateral CF per ablation in segment (third) of acute or delayed reconnection. Determined during index and repeat RFA procedure
Secondary Average axial CF of segment of acute and delayed reconnection Average axial CF per ablation in segment (third) of acute or delayed reconnection. Determined during index and repeat RFA procedure
Secondary Average FTI of segment of acute and delayed reconnection Average FTI per ablation in segment (third) of acute or delayed reconnection. Determined during index and repeat RFA procedure
Secondary Average lesion size index (LSI) of segment of acute and delayed reconnection Average lesion size index (LSI) per ablation in segment (third) of acute or delayed reconnection. Determined during index and repeat RFA procedure
Secondary Procedural efficacy of RFA Total procedural time required to achieve bidirectional block Determined during RFA procedure
See also
  Status Clinical Trial Phase
Recruiting NCT05416086 - iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study N/A
Terminated NCT02317029 - Comparison of Oxygen Interventions and Defibrillator Efficiency N/A
Recruiting NCT01563848 - Cryoablation in Patients With Atrial Flutter Phase 2
Completed NCT01229254 - Evaluate the Pharmacokinetics and Safety of MK-4448 in Participants With Nonvalvular Atrial Fibrillation or Atrial Flutter Phase 2
Completed NCT00839657 - Clarification of Optimal Anticoagulation Through Genetics Phase 3
Completed NCT02065388 - Pharmacogenetic Dosing of Warfarin Phase 3
Completed NCT00232232 - Use of Fish Oils to Prevent Atrial Mechanical Stunning and Atrial Remodeling Due to Atrial Arrhythmia Phase 4
Completed NCT04884100 - enHEART - Exploring Full Content of Optical Signals to Enhance Cardiac Arrhythmia Screening N/A
Completed NCT05468281 - RAFF5 Proposal: Improve the Quality and Safety of Patients Seen in the Emergency Department for Acute Atrial Fibrillation and Flutter
Completed NCT03627143 - Decreasing Hospital Admissions From the ED for AAFF N/A
Completed NCT02917538 - A Randomized Trial of Contact Force in Atrial Flutter Ablation N/A
Enrolling by invitation NCT05903313 - A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software
Recruiting NCT05755074 - Ablation of Typical Right Atrial Flutter N/A
Recruiting NCT05883631 - RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy. N/A
Recruiting NCT03272620 - Atrial Fibrillation at the Viennese University Emergency Department N/A
Completed NCT02810938 - MIFI Flutter Registry - Ablation of Atrial Flutter With IntellaTip Sensor Technology
Recruiting NCT02591875 - Atrial Flutter Ablation in a Real World Population N/A
Completed NCT01914497 - Dipole Density Mapping of Typical Atrial Flutter N/A
Completed NCT02268799 - High Sensitivity Troponin T Levels Following DC Cardioversion for Atrial Fibrillation / Atrial Flutter N/A
Active, not recruiting NCT01976507 - Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism Phase 4